相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Higher Lipopolysaccharide Binding Protein and Chemerin Concentrations Were Associated with Metabolic Syndrome Features in Pediatric Subjects with Abdominal Obesity during a Lifestyle Intervention
Amelia Marti et al.
NUTRIENTS (2021)
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial
Noel T. Mueller et al.
DIABETES CARE (2021)
Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized Trial
Hsin-Chieh Yeh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Regulation of adipose tissue inflammation by interleukin 6
Myoung Sook Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian et al.
CURRENT OBESITY REPORTS (2019)
Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial Arabinoxylans in gut barrier
Bouke N. Salden et al.
CLINICAL NUTRITION (2018)
The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial
Antonio Gonzalez-Sarrias et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction
Antje Damms-Machado et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu et al.
NATURE MEDICINE (2017)
Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women
Beate Ott et al.
SCIENTIFIC REPORTS (2017)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery
Mercedes Clemente-Postigo et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2015)
Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese
Xin Liu et al.
DIABETOLOGIA (2014)
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction
Jose Maria Moreno-Navarrete et al.
DIABETOLOGIA (2013)
Obesity and C-reactive protein in various populations: a systematic review and meta-analysis
J. Choi et al.
OBESITY REVIEWS (2013)
Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity
Arturo Gonzalez-Quintela et al.
PLOS ONE (2013)
Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance
J. M. Moreno-Navarrete et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
Lawrence J. Appel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Association of upopolysaccharide-binding protein and coronary artery disease in men
Philipp M. Lepper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
Body size and shape changes and the risk of diabetes in the diabetes prevention program
Wilfred Y. Fujimoto et al.
DIABETES (2007)
Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery
FMH van Dielen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock
ES Van Amersfoort et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)